Search results
Dr. Zheng is well known for his work on molecular, genetic and nutritional epidemiology of breast and colorectal cancers. Over the past 15 years, he has initiated five large international consortia/pooling projects and collaborated on >30 other research consortia. He has authored or co-authored more than 1,100 publications addressing a large ...
- Staff
Lead Program Manager, Vanderbilt Tuberculosis Center and...
- Members
Wei Zheng. Professor and Director, Vanderbilt Epidemiology...
- Education and Training
Vanderbilt MPH Class of 2023, Global Health Track. We’re so...
- Graduate Certificate in Global Health
For Students Interested in Multiple Graduate Certificates:...
- Academic Programs
Immersion Course. VIGH and VUSM have developed an immersion...
- Staff
Dr. Zheng has directed more than 20 large-scale, population-based studies, including several international consortia. In 2008 and 2009, he initiated two genetic research consortia for breast and colorectal cancers in Asians - currently including nearly 200,000 cases and controls from more than 40 studies - which have identified over 30 novel susceptibility loci/variants.
- Areas of Expertise
- Biography
- Education
- Current Courses
- Selected Honors/Awards
- Selected Grants
- Professional Affiliations
- In The News
To explore mechanisms by which lead (Pb) exposure alters beta-amyloid transport by brain barrier systems and affects the homeostasis of beta-amyloid in the central milieu, leading to cerebral amylo...To explore mechanisms, biomarkers and chelation therapy of manganese (Mn)-induced Parkinsonian disorder, by using laboratory animal models, human cohorts and noninvasive technical assessment of cum...To explore the role of copper (Cu) in adult neurogenesis in subventricular zone (SVZ) and to understand how the choroid plexus in brain ventricles contributes to the regulation of adult neurogenesi...Transport of substances (metals, polypeptides, and drug molecules) by the blood-brain barrier and blood-CSF barrier.Dr. Wei Zheng started his academic career in New York City initially as an Assistant Professor (1993-2000) and later Associate Professor (2000-2003) in School of Public Health and College of Physicians and Surgeons at Columbia University. He joined Purdue University in 2003 and became a Full Professor in 2006. Having served a decade as the former h...
PhD in Pharmacology and Toxicology, 1991, University of ArizonaMS in Pharmacology, 1984, Zhejiang UniversityBS in Pharmacy, 1981, Zhejiang UniversityHSCI 101 - Introduction to Health Sciences ProfessionsHSCI 360 - Everyday Toxicology: Poisonings from Clinics to CourtroomsHSCI 290 - Teaching Experience in Heath Sciences ProfessionsFellow, the U.S. Academy of Toxicological Sciences - 2016Education Award, Society of Toxicology - 2021Career Achievement Award, the Society of Toxicology Metals Specialty Section - 2015Career Research Achievement Award, Purdue University/HHS - 2020Principal Investigator; Lead Exposure and Beta-Amyloid Transport by Brain Barriers. National Institute of Environmental Health (R01 ES027078). Period: 07/01/2017-06/30/2022. Total: $1,919,925.Co-Investigator, Imaging Biomarkers of Neurotoxicity in Welders. National Institute on Aging (R01 AG021488). Brad Racette (PI). Period: 07/01/2021 - 06/30/2026. Total: $2,120,096.Co-Investigator, The Pathogenic Role of Lead in Cerebral Amyloid Angiopathy and AD. National Institute on Aging (R21 AG067923). Yansheng Du and Paul Territo (MPI). Period: 02/01/2020 - 11/30/2022....Principal Investigator; Development of a High Through-Put System for Study of Transport of Drugs across Brain Barriers. Johnson & Johnson Corp. (2003111191). Period: unlimited. Total: $255,000Member of Society of Toxicology since 1994. President of the Metals Specialty Section (2009-2010); Chair of the Board of Publication (2016-2019)Member of International Society for Trace Elements Research in Humans (ISTERH). Vice President-Elect (2015), Vice President (2017), President (2019), Acting President (2021-2022). Chairman of the I...Founding member of American Association for Chinese in Toxicology (AACT), President (1991-1992)Jul 29, 2024 · Last updated on July 29, 2024. 9609 Medical Center Drive. Rockville, MD 20850-9793. 301-594-8966. ncatsinfo@nih.gov. Wei Zheng, M.D., Ph.D., is a group leader of a team of biologists and pharmacologists in the Therapeutic Development Branch within NCATS’ Division of Preclinical Innovation.
Dr. Wei Zheng: My name is Wei Zheng. I’m a professor of medicine at Vanderbilt University Medical Center. I’m also the director for the Division of Epidemiology and associate director for population sciences at the cancer center. So this is a large prospective cohort study.
J Inglese, RL Johnson, A Simeonov, M Xia, W Zheng, CP Austin, DS Auld. Nature chemical biology 3 (8), 466-479. , 2007. 757. 2007. Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen.
People also ask
Who is Wei Zheng?
Who is Dr Zheng?
Who is Dr Zheng from Vanderbilt Epidemiology Center?
Who is Dr. Wei Zhang?
Who is Dr Weihong Zheng?
When did Dr Zheng join Purdue?
Department of Medicine. Wei Zheng, MD, PhD, MPH, is the Anne Potter Wilson Professor in Medicine, Director of the Division of Epidemiology, and Director of the Vanderbilt Epidemiology Center at Vanderbilt University Medical Center. He also serves as the Associate Director for Population Sciences Research at the Vanderbilt-Ingram Cancer Center.
